prednisone has been researched along with Hepatitis B in 195 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among patients seropositive for the hepatitis B surface antigen with diffuse large B-cell lymphoma undergoing R-CHOP chemotherapy, the addition of entecavir compared with lamivudine resulted in a lower incidence of HBV-related hepatitis and HBV reactivation." | 9.19 | Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial. ( Cao, Y; Huang, H; Li, H; Li, X; Lin, S; Lin, T; Lin, Y; Liu, Q; Peng, J; Wang, W; Wu, X; Xu, B; Ye, S; Zhang, H; Zhu, J, 2014) |
| "Among the adult Chinese patients with MSNS-HBV who completed this study, there were no significant differences in remission rates of idiopathic nephrotic syndrome between the standard prednisone regimen and the combination of MMF and a reduced prednisone dose." | 9.14 | A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study. ( Chen, J; Chen, Y; Han, F; He, Q; Li, H; Li, Q; Li, X; Ni, Q; Tian, J; Wu, J, 2009) |
| "To assess the efficacy and safety of lamivudine, an antiviral agent that strongly inhibits hepatitis B virus (HBV) DNA replication, combined with plasma exchanges after short-term corticosteroids for HBV-related polyartertitis nodosa (PAN)." | 9.11 | Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. ( Bielefeld, P; Cohen, P; Guillevin, L; Hausfater, P; Imbert, B; Larroche, C; Loustaud-Ratti, V; Mahr, A; Petitjean, P; Queyrel, V; Roudier, J; Smadja, D, 2004) |
| "The outcome of 31 children with HB e antigen (HBeAg)-positive chronic hepatitis who randomly received either no treatment (n = 9) or 10 million units of interferon alpha-2b/m2, alone (n = 13) or after prednisone priming (n = 9), three times weekly for 1 year was studied." | 9.08 | Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection. ( Ammendola, R; De Vincenzo, A; Fontanella, A; Novissimo, A; Tedesco, M; Terracciano, LM; Vajro, P; Vecchione, R; Vegnente, A, 1996) |
| "To assess the effects of prednisone and interferon on the distribution of hepatitis B virus (HBV) precore mutants, nine hepatitis B e antibody (HBeAb)-positive patients with HBV chronic infection were studied." | 9.08 | Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon. ( Bartolome, J; Cabrerizo, M; Carreño, V; Cotonat, T; Lopez-Alcorocho, JM, 1995) |
| "In a randomized, controlled trial of recombinant interferon alfa-2b with or without prednisone priming in Chinese adults with chronic hepatitis B virus infection, stratified randomization for pretreatment serum alanine aminotransferase levels was done." | 9.07 | A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. ( Chung, HT; Lai, CL; Lau, JY; Lauder, IJ; Leung, EK; Lok, AS; Ma, OC; Ng, CP; Wong, LS; Wu, PC, 1992) |
| "A six-month analysis of a controlled trial on the treatment of chronic hepatitis B in children shows that prednisone priming followed by alpha-interferon 2A was effective in 6 of 9 treated patients in reducing HBV replication and disease activity." | 9.07 | Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial. ( Adinolfi, LE; Aprea, L; Cesaro, G; Digilio, L; Galanti, B; Giusti, G; Piccinino, F; Ruggiero, G; Sagnelli, E; Utili, R, 1992) |
| "The efficacy and safety of sequential treatment with prednisone and interferon was evaluated in a randomized, controlled study on 43 children with biopsy proven HBsAg/HBeAg/hepatitis B virus-DNA positive, anti-delta negative, chronic hepatitis (34 chronic persistent hepatitis, 9 chronic active hepatitis)." | 9.07 | Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study. ( Aprea, L; Felaco, FM; Gaeta, GB; Galanti, B; Marrone, A; Nardiello, S; Pasquale, G; Pizzella, T; Sagnelli, E; Utili, R, 1994) |
| "Hepatitis B e antigen and hepatitis B viral DNA disappeared from serum significantly more often in the patients given prednisone plus interferon (16 of 44 patients, or 36 percent) or 5 million units of interferon alone (15 of 41; 37 percent) than in the untreated controls (3 of 43; 7 percent; P less than 0." | 9.06 | A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. ( Albrecht, J; Bodenheimer, HC; Davis, GL; Dienstag, JL; Feit, D; Gibas, A; Jacobson, IM; Kuhns, M; Lefkowitch, J; Lindsay, K; Meschievitz, C; O'Brien, C; Payne, J; Perrillo, RP; Sampliner, R; Sanghvi, B; Schiff, ER; Tamburro, C, 1990) |
| "A prospective, double-blind study was carried out to assess the efficacy of interferon alfa-2b, with or without pre-treatment prednisone withdrawal, in patients with chronic hepatitis B." | 9.06 | Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. ( Adler, M; Desmet, V; Elewaut, A; Fevery, J; Michielsen, P; Nevens, F; Van Eyken, P, 1990) |
| "The aim of this study was to review all published randomized clinical trials evaluating the efficacy of a combination of prednisone and interferon in treatment of chronic hepatitis B and to subject these studies to metanalysis." | 8.79 | Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis. ( Cohard, M; Mathurin, P; Poynard, T; Zarski, JP, 1994) |
| "The aim of the present study was to investigate the relationship between hypothyroidism and thrombocytopenia in hepatitis B-related compensatory liver cirrhosis and to determine whether treatment with levothyroxine and prednisone is superior in a multicenter, open-label, observational study in China." | 7.88 | Combined prednisone and levothyroxine improve treatment of severe thrombocytopenia in hepatitis B with compensatory cirrhosis accompanied by subclinical and overt hypothyroidism. ( Feng, R; Fu, H; Huang, X; Jiang, H; Jiang, Q; Liu, H; Liu, K; Lu, J; Niu, T; Wang, H; Wang, J; Wang, X; Xie, Y; Xu, L; Xue, J; Zhang, X, 2018) |
| " We assessed the hepatotoxicity of methotrexate and prednisolone combination therapy in the background of hepatitis B virus infection." | 7.80 | Fibrosing cholestatic hepatitis after methotrexate and prednisone therapy for rheumatoid arthritis. ( Çalık, A; Çeşmecioğlu, E; Çobanoğlu, Ü; Kalaycı, O; Topaloğlu, S; Uzun, Y, 2014) |
| "This is the first report describing HBV reactivation in an occult HBV infection patient treated with oral prednisone for nephrotic syndrome." | 7.79 | HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review. ( Chen, S; Du, W; Han, S; Ma, S; Zheng, Z, 2013) |
| "The results of lamivudine therapy in 4 patients with chemotherapy-induced hepatitis B virus (HBV) reactivation are reported." | 7.72 | Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine. ( Ahmed, A; Ahmed, AM; Garcia, G; Keeffe, EB; Nguyen, MH; Simpson, ND; Simpson, PW, 2003) |
| "The level of serum-soluble interleukin-2 receptor (sIL-2R) was measured in 32 patients to investigate the effect of prednisone and alpha-interferon therapy on chronic hepatitis B virus infection." | 7.68 | Effects of alpha-interferon and prednisone on serum-soluble interleukin-2 receptor (sIL-2R) in chronic hepatitis B infection. ( Lai, KN; Lau, JT; Leung, JC; Leung, NW; Tam, JS, 1992) |
| "We have studied the effect of short-term high-dose prednisone therapy on aminotransferase levels and hepatitis B virus markers in 6 patients with chronic type B hepatitis." | 7.66 | Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. ( Rakela, J; Redeker, AG; Weliky, B, 1983) |
| "Lamivudine (LAM) was administered orally from the start of R-CHOP." | 5.34 | [Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma]. ( Hayashi, T; Iyama, S; Kato, J; Kawano, Y; Kobune, M; Matsunaga, T; Miyanishi, K; Niitsu, Y; Okuda, T; Ono, K; Sagawa, T; Sato, T; Sato, Y; Takada, K; Takimoto, R, 2007) |
| " It is possible that lamivudine combined with chemotherapy may have had a therapeutic effect on ATL in this case." | 5.33 | [Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy]. ( Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T, 2006) |
| "During treatment Hepatitis B was reactivated and after termination, of chemotherapy she developed fulminant hepatitis with hyperbilirubinemia, coagulopathy, hypoalbuminemia and ascites." | 5.31 | [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration]. ( Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M, 2001) |
| "Lamivudine, 100 mg/d, was given orally from the start until 1 month after the end of chemotherapy, which included corticosteroids and/or purine analogues in 85% of cases." | 5.31 | Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. ( Motta, M; Pelizzari, A; Puoti, M; Rossi, G, 2001) |
| "Among patients seropositive for the hepatitis B surface antigen with diffuse large B-cell lymphoma undergoing R-CHOP chemotherapy, the addition of entecavir compared with lamivudine resulted in a lower incidence of HBV-related hepatitis and HBV reactivation." | 5.19 | Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial. ( Cao, Y; Huang, H; Li, H; Li, X; Lin, S; Lin, T; Lin, Y; Liu, Q; Peng, J; Wang, W; Wu, X; Xu, B; Ye, S; Zhang, H; Zhu, J, 2014) |
| "Among the adult Chinese patients with MSNS-HBV who completed this study, there were no significant differences in remission rates of idiopathic nephrotic syndrome between the standard prednisone regimen and the combination of MMF and a reduced prednisone dose." | 5.14 | A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study. ( Chen, J; Chen, Y; Han, F; He, Q; Li, H; Li, Q; Li, X; Ni, Q; Tian, J; Wu, J, 2009) |
| "To assess the efficacy and safety of lamivudine, an antiviral agent that strongly inhibits hepatitis B virus (HBV) DNA replication, combined with plasma exchanges after short-term corticosteroids for HBV-related polyartertitis nodosa (PAN)." | 5.11 | Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. ( Bielefeld, P; Cohen, P; Guillevin, L; Hausfater, P; Imbert, B; Larroche, C; Loustaud-Ratti, V; Mahr, A; Petitjean, P; Queyrel, V; Roudier, J; Smadja, D, 2004) |
| "The outcome of 31 children with HB e antigen (HBeAg)-positive chronic hepatitis who randomly received either no treatment (n = 9) or 10 million units of interferon alpha-2b/m2, alone (n = 13) or after prednisone priming (n = 9), three times weekly for 1 year was studied." | 5.08 | Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection. ( Ammendola, R; De Vincenzo, A; Fontanella, A; Novissimo, A; Tedesco, M; Terracciano, LM; Vajro, P; Vecchione, R; Vegnente, A, 1996) |
| "To assess the effects of prednisone and interferon on the distribution of hepatitis B virus (HBV) precore mutants, nine hepatitis B e antibody (HBeAb)-positive patients with HBV chronic infection were studied." | 5.08 | Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon. ( Bartolome, J; Cabrerizo, M; Carreño, V; Cotonat, T; Lopez-Alcorocho, JM, 1995) |
| "A six-month analysis of a controlled trial on the treatment of chronic hepatitis B in children shows that prednisone priming followed by alpha-interferon 2A was effective in 6 of 9 treated patients in reducing HBV replication and disease activity." | 5.07 | Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial. ( Adinolfi, LE; Aprea, L; Cesaro, G; Digilio, L; Galanti, B; Giusti, G; Piccinino, F; Ruggiero, G; Sagnelli, E; Utili, R, 1992) |
| "In a randomized, controlled trial of recombinant interferon alfa-2b with or without prednisone priming in Chinese adults with chronic hepatitis B virus infection, stratified randomization for pretreatment serum alanine aminotransferase levels was done." | 5.07 | A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. ( Chung, HT; Lai, CL; Lau, JY; Lauder, IJ; Leung, EK; Lok, AS; Ma, OC; Ng, CP; Wong, LS; Wu, PC, 1992) |
| "To re-evaluate the efficacy of 3 treatment trials involving 272 Chinese patients with chronic hepatitis B virus infection, serial serum samples were tested from 60 patients treated with alpha-interferon with or without prednisone priming and 12 control patients, who were negative for hepatitis B virus deoxyribonucleic acid using dot-blot hybridization." | 5.07 | Re-evaluation of alpha-interferon treatment of chronic hepatitis B using polymerase chain reaction. ( Chung, HT; Lai, CL; Lok, AS, 1993) |
| "The efficacy and safety of sequential treatment with prednisone and interferon was evaluated in a randomized, controlled study on 43 children with biopsy proven HBsAg/HBeAg/hepatitis B virus-DNA positive, anti-delta negative, chronic hepatitis (34 chronic persistent hepatitis, 9 chronic active hepatitis)." | 5.07 | Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study. ( Aprea, L; Felaco, FM; Gaeta, GB; Galanti, B; Marrone, A; Nardiello, S; Pasquale, G; Pizzella, T; Sagnelli, E; Utili, R, 1994) |
| "Eleven patients with hepatitis B e antigen (HBeAg)-positive chronic active hepatitis B were treated with an 8-wk course of prednisone followed by 28 days of adenine arabinoside 5'-monophosphate." | 5.06 | The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication. ( Perrillo, RP, 1986) |
| "Hepatitis B e antigen and hepatitis B viral DNA disappeared from serum significantly more often in the patients given prednisone plus interferon (16 of 44 patients, or 36 percent) or 5 million units of interferon alone (15 of 41; 37 percent) than in the untreated controls (3 of 43; 7 percent; P less than 0." | 5.06 | A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. ( Albrecht, J; Bodenheimer, HC; Davis, GL; Dienstag, JL; Feit, D; Gibas, A; Jacobson, IM; Kuhns, M; Lefkowitch, J; Lindsay, K; Meschievitz, C; O'Brien, C; Payne, J; Perrillo, RP; Sampliner, R; Sanghvi, B; Schiff, ER; Tamburro, C, 1990) |
| "A prospective, double-blind study was carried out to assess the efficacy of interferon alfa-2b, with or without pre-treatment prednisone withdrawal, in patients with chronic hepatitis B." | 5.06 | Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. ( Adler, M; Desmet, V; Elewaut, A; Fevery, J; Michielsen, P; Nevens, F; Van Eyken, P, 1990) |
| "The aim of this study was to review all published randomized clinical trials evaluating the efficacy of a combination of prednisone and interferon in treatment of chronic hepatitis B and to subject these studies to metanalysis." | 4.79 | Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis. ( Cohard, M; Mathurin, P; Poynard, T; Zarski, JP, 1994) |
| "We prospectively enrolled patients with negative hepatitis B surface antigen positive Anti-hepatitis B core status with or without corticosteroid use and determined corticosteroid exposure by calculating cumulative dose and time-weighted average daily dose of prednisone." | 4.12 | Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection. ( Dai, L; Feng, X; Gao, Y; Liao, W; Su, G; Wu, Q; Yang, P; Zhong, Z, 2022) |
| " Nine years earlier, the patient had been diagnosed with diffuse large B-cell lymphoma (DLBCL) and undergone rituximab, cyclophosphamide, doxorubicin hydrochloride, oncovin, prednisone (R-CHOP) therapy." | 3.96 | Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate. ( Fukuda, H; Fukuda, S; Fukunaga, A; Hirai, F; Irie, M; Kunimoto, H; Morihara, D; Sakisaka, S; Sakurai, K; Shakado, S; Takata, K; Takeyama, Y; Tanaka, T; Umeda, K; Yamauchi, R; Yokoyama, K, 2020) |
| "The aim of the present study was to investigate the relationship between hypothyroidism and thrombocytopenia in hepatitis B-related compensatory liver cirrhosis and to determine whether treatment with levothyroxine and prednisone is superior in a multicenter, open-label, observational study in China." | 3.88 | Combined prednisone and levothyroxine improve treatment of severe thrombocytopenia in hepatitis B with compensatory cirrhosis accompanied by subclinical and overt hypothyroidism. ( Feng, R; Fu, H; Huang, X; Jiang, H; Jiang, Q; Liu, H; Liu, K; Lu, J; Niu, T; Wang, H; Wang, J; Wang, X; Xie, Y; Xu, L; Xue, J; Zhang, X, 2018) |
| " We assessed the hepatotoxicity of methotrexate and prednisolone combination therapy in the background of hepatitis B virus infection." | 3.80 | Fibrosing cholestatic hepatitis after methotrexate and prednisone therapy for rheumatoid arthritis. ( Çalık, A; Çeşmecioğlu, E; Çobanoğlu, Ü; Kalaycı, O; Topaloğlu, S; Uzun, Y, 2014) |
| "This is the first report describing HBV reactivation in an occult HBV infection patient treated with oral prednisone for nephrotic syndrome." | 3.79 | HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review. ( Chen, S; Du, W; Han, S; Ma, S; Zheng, Z, 2013) |
| "A decision model was developed to compare the clinical outcomes, costs, and cost effectiveness of three HBV screening strategies for patients with lymphoma before R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy: screen all patients for hepatitis B surface antigen (HBsAg; Screen-All), screen patients identified as being at high risk for HBV infection (Screen-HR), and screen no one (Screen-None)." | 3.78 | Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis. ( Bell, CM; Chan, KK; Feld, JJ; Hicks, LK; Krahn, M; Woo, G; Zurawska, U, 2012) |
| " We report a 67-year-old man with B-cell lymphoma who developed hepatitis B reactivation following chemotherapy with cyclophosphamide, adriamycin, vincristine, prednisone and rituximab." | 3.73 | Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. ( Erb, SR; Ho, JK; Hoskins, PJ; Law, JK; Steinbrecher, UP; Yoshida, EM, 2005) |
| "The results of lamivudine therapy in 4 patients with chemotherapy-induced hepatitis B virus (HBV) reactivation are reported." | 3.72 | Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine. ( Ahmed, A; Ahmed, AM; Garcia, G; Keeffe, EB; Nguyen, MH; Simpson, ND; Simpson, PW, 2003) |
| " Each treatment arm of the prospective therapeutic trials was also tested: 1) prednisone (CS) + oral cyclophosphamide (CYC) + plasma exchanges (PE) versus CS E, 2) CS + PE versus CS, 3) CS + oral CY versus CS + pulse CY, 4) CS + pulse CY + PE versus CS + pulse CY in severe PAN and CSS, and 5) PE + antiviral agents after short-term CS in hepatitis B virus-related PAN." | 3.69 | Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. ( Casassus, P; Cohen, P; Gayraud, M; Guillevin, L; Jarrousse, B; Lhote, F; Lortholary, O; Thibult, N, 1996) |
| "The level of serum-soluble interleukin-2 receptor (sIL-2R) was measured in 32 patients to investigate the effect of prednisone and alpha-interferon therapy on chronic hepatitis B virus infection." | 3.68 | Effects of alpha-interferon and prednisone on serum-soluble interleukin-2 receptor (sIL-2R) in chronic hepatitis B infection. ( Lai, KN; Lau, JT; Leung, JC; Leung, NW; Tam, JS, 1992) |
| "To determine the effect of corticosteroids on the replication of hepatitis B virus and to assess the relationship between virus replication and prognosis, the behavior of serum and tissue HBcAg was evaluated in 16 patients with severe HBsAg-positive chronic active hepatitis who were treated with prednisone and followed for up to 10 years (mean +/- SEM, 66 +/- 9 months)." | 3.67 | Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis. ( Czaja, AJ; Davis, GL; Go, VL; Ludwig, J; Taswell, HF, 1985) |
| "Hepatitis B virus associated DNA polymerase activity, hepatitis b surface antigen (HBsAg), and serum aspartate aminotransferase were followed in 21 patients with chronic active hepatitis while immunosuppressive therapy (prednisone +/- azathioprine) was being withdrawn." | 3.66 | Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. ( Gregory, PB; Merigan, TC; Robinson, WS; Scullard, GH; Smith, CI, 1981) |
| "We have studied the effect of short-term high-dose prednisone therapy on aminotransferase levels and hepatitis B virus markers in 6 patients with chronic type B hepatitis." | 3.66 | Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. ( Rakela, J; Redeker, AG; Weliky, B, 1983) |
| "Fifty-six patients with biopsy-proven, chronic active hepatitis B were included in a multi-center, randomized trial comparing steroid withdrawal followed by 1." | 2.67 | Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. Swiss Association for the Study of the Liver. ( Bianchi, L; Frei, PC; Lavanchy, D; Malé, PJ; Reichen, J; Schmid, M, 1994) |
| "Prednisone pretreatment does not seem to have any additional benefit to using interferon alone in these patients, while the effect in patients with elevated aminotransferase levels remains to be proven." | 2.67 | Alpha-interferon treatment in Chinese patients with chronic hepatitis B. ( Fung, YL; Lai, CL; Lau, JY; Leung, EK; Lok, AS; Wong, LS; Wu, PC, 1990) |
| "Prednisone pretreatment did not seem to improve the efficacy of interferon therapy." | 2.67 | [Treatment of chronic hepatitis B with interferon alpha (Wellferon) with and without previous corticosteroid therapy -- results of a multicenter, double blind study]. ( Cianciara, J; Gładysz, A; Juszczyk, J; Laskus, T; Loch, T; Mach, G; Machaj, A; Simon, K, 1992) |
| "Thirty-eight patients with chronic active hepatitis type B received antiviral therapy." | 2.66 | Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B. ( Bodicky, CJ; Campbell, CR; Perrillo, RP; Regenstein, FG; Sanders, GE; Sunwoo, YC, 1985) |
| "The occurrence of acquired hemophilia A (AHA) is low and so the coexistence of EBA and AHA is extremely rare." | 2.55 | Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review. ( He, CX; Hua, BL; Jin, HZ; Li, L; Liu, YH; Yan, TM; Zuo, YG, 2017) |
| " Preliminary results seem to indicate, that the dosage used may be reduced slowly and therapy finally stopped after 3-4 years of treatment in most patients." | 2.36 | [Therapy of chronic hepatitis (author's transl)]. ( Arnold, W; Meyer zum Büschenfelde, KH, 1981) |
| "Treatment with prednisone or/and immunosuppressive drugs significantly reduced the frequency of CD4(+)CXCR5(+), CD4(+)CXCR5(+)PD-1(+) TFH cells and serum IL-21 level, but increased IL-4 and IL-10 levels in the patients." | 1.40 | Frequency of CD4+CXCR5+ TFH cells in patients with hepatitis b virus-associated membranous nephropathy. ( Ayana, DA; Jiang, Y; Liu, Y; Qu, Z; Zhao, P, 2014) |
| "Among these patients, 7 had Burkitt lymphoma (BL), 20 had diffuse large B cell lymphoma (DLBCL), 7 had plasmablastic lymphoma (PL), and 1 had primary effusion lymphoma (PEL)." | 1.40 | Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era. ( Adamski, M; Gunthel, C; Mosunjac, M; Nguyen, ML; Silverton, A, 2014) |
| " Patients with documented HBV reactivation were treated with entecavir at a dosage of 0." | 1.40 | Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. ( Chang, CS; Chen, PJ; Cheng, AL; Chiu, CF; Hsu, C; Hwang, WL; Kao, WY; Lin, J; Lin, SF; Lin, SJ; Liu, TW; Tien, HF; Tsou, HH; Wang, MC; Yao, M, 2014) |
| "The prognosis and management of acute exacerbations of hepatitis-B in patients with lymphoma after chemotherapy in combination with rituximab remain unclear." | 1.36 | Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma. ( Chen, ZH; Dong, M; Li, X; Lin, Q; Ma, XK; Wei, L; Wen, JY; Wu, XY, 2010) |
| "Secondary or reactive hemophagocytic syndrome is frequently related to viral infections and is named Virus-Associated Hemophagocytic Syndrome (VAHS)." | 1.35 | Virus-Associated Hemophagocytic Syndrome related to acute CMV and HBV sexual co-infection: a case report. ( Halfon, P; Helbert, T; Mathieu, D; Pégliasco, H; Philibert, P; Retornaz, F, 2009) |
| "Lamivudine (LAM) was administered orally from the start of R-CHOP." | 1.34 | [Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma]. ( Hayashi, T; Iyama, S; Kato, J; Kawano, Y; Kobune, M; Matsunaga, T; Miyanishi, K; Niitsu, Y; Okuda, T; Ono, K; Sagawa, T; Sato, T; Sato, Y; Takada, K; Takimoto, R, 2007) |
| " It is possible that lamivudine combined with chemotherapy may have had a therapeutic effect on ATL in this case." | 1.33 | [Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy]. ( Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T, 2006) |
| "During treatment Hepatitis B was reactivated and after termination, of chemotherapy she developed fulminant hepatitis with hyperbilirubinemia, coagulopathy, hypoalbuminemia and ascites." | 1.31 | [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration]. ( Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M, 2001) |
| "Lamivudine, 100 mg/d, was given orally from the start until 1 month after the end of chemotherapy, which included corticosteroids and/or purine analogues in 85% of cases." | 1.31 | Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. ( Motta, M; Pelizzari, A; Puoti, M; Rossi, G, 2001) |
| " Two patients developed exacerbation of hepatitis when the dosage of prednisolone was reduced after they had ten weeks of high dose prednisolone." | 1.29 | Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies. ( Chong, R; Goh, YT; Lee, LH; Ng, HS; Tan, P; Wong, GC, 1996) |
| "In summary, in treating hepatitis B viral infection, no single agent is totally effective and perhaps the combination of suppressing viral replication and augmenting the immune system is the optimal way to eradicate the virus." | 1.28 | Alpha-interferon combined with immunomodulation in the treatment of chronic hepatitis B. ( Peters, M, 1991) |
| "When prednisone therapy was stopped, the patient rapidly passed from the prodrome to typical, acute, icteric hepatitis." | 1.27 | Prolongation of the prodrome to acute hepatitis B infection by corticosteroids. ( Johnson, BE; Reed, JS, 1983) |
| "When vidarabine was prescribed as treatment of acute periarteritis nodosa (the 2 cases where it was used for chronic hepatitis being excluded), this response rate was 37." | 1.27 | [Periarteritis nodosa related to hepatitis B virus. Determination of a new therapeutic strategy: 13 cases]. ( Baudelot, J; Gayraud, M; Guillevin, L; Jarrousse, B; Léon, A; Merrouche, Y; Royer, I, 1988) |
| "Prednisone therapy was associated with complete clearing of all clinical and laboratory abnormalities." | 1.26 | Hepatitis-associated lipid storage myopathy. ( Alperin, J; Dodson, RF; Patten, BM; Shabot, JM, 1977) |
| "The link between ulcerative colitis, the chronic hepatopathy and the development of Hodgkin's disease that could have arisen as a consequence of the prolonged immunosuppressive treatment are discussed." | 1.26 | [Hodgkin's disease developing in the course of a chronic liver disease with ulcerative colitis immunosuppressed with azathioprine]. ( Findor, JA; Orbuch, SJ, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 74 (37.95) | 18.7374 |
| 1990's | 57 (29.23) | 18.2507 |
| 2000's | 29 (14.87) | 29.6817 |
| 2010's | 30 (15.38) | 24.3611 |
| 2020's | 5 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, Z | 1 |
| Liao, W | 1 |
| Dai, L | 1 |
| Feng, X | 1 |
| Su, G | 1 |
| Gao, Y | 1 |
| Wu, Q | 1 |
| Yang, P | 1 |
| Feng, R | 2 |
| Liu, Y | 2 |
| Zhu, XL | 1 |
| Zhai, WY | 1 |
| He, Y | 1 |
| Fu, HX | 1 |
| Jiang, Q | 2 |
| Jiang, H | 2 |
| Lu, J | 2 |
| Liu, H | 2 |
| Wang, JW | 1 |
| Wang, H | 2 |
| Xie, YD | 1 |
| Ma, H | 1 |
| Huang, XJ | 1 |
| Zhang, XH | 1 |
| Yamauchi, R | 1 |
| Takeyama, Y | 1 |
| Takata, K | 1 |
| Fukunaga, A | 1 |
| Sakurai, K | 1 |
| Tanaka, T | 1 |
| Fukuda, H | 1 |
| Fukuda, S | 1 |
| Kunimoto, H | 1 |
| Umeda, K | 1 |
| Morihara, D | 1 |
| Yokoyama, K | 1 |
| Irie, M | 1 |
| Shakado, S | 1 |
| Sakisaka, S | 1 |
| Hirai, F | 1 |
| Huang, HH | 1 |
| Hsiao, FY | 1 |
| Chen, HM | 1 |
| Wang, CY | 1 |
| Ko, BS | 1 |
| Yamauchi, N | 1 |
| Maruyama, D | 1 |
| Choi, I | 1 |
| Atsuta, Y | 1 |
| Sakai, R | 1 |
| Miyashita, K | 1 |
| Moriuchi, Y | 1 |
| Tsujimura, H | 1 |
| Kubota, N | 1 |
| Yamamoto, G | 1 |
| Igarashi, T | 1 |
| Izutsu, K | 1 |
| Yoshida, S | 1 |
| Kojima, K | 1 |
| Uchida, T | 1 |
| Inoue, Y | 1 |
| Tsukamoto, N | 2 |
| Ohtsuka, E | 1 |
| Suzuki, S | 1 |
| Inaguma, Y | 1 |
| Ichikawa, S | 1 |
| Gomyo, H | 1 |
| Ushijima, Y | 1 |
| Nosaka, K | 1 |
| Kurata, M | 1 |
| Tanaka, Y | 1 |
| Ueda, R | 1 |
| Mizokami, M | 1 |
| Kusumoto, S | 1 |
| Crespo, J | 1 |
| Esteban, R | 1 |
| Torres, C | 1 |
| Oyagüez, I | 1 |
| Casado, MÁ | 1 |
| Buti, M | 1 |
| Xue, J | 1 |
| Fu, H | 1 |
| Wang, J | 2 |
| Niu, T | 1 |
| Wang, X | 1 |
| Xie, Y | 1 |
| Xu, L | 1 |
| Liu, K | 1 |
| Huang, X | 1 |
| Zhang, X | 1 |
| Yan, X | 1 |
| Zhou, M | 1 |
| Lou, Z | 1 |
| Mu, Q | 1 |
| Sheng, L | 1 |
| Zhang, P | 1 |
| Wang, Y | 1 |
| Ouyang, G | 1 |
| Zhou, X | 1 |
| Wuchter, P | 1 |
| Egerer, G | 1 |
| Kriegsmann, M | 1 |
| Mataityte, A | 1 |
| Koelsche, C | 1 |
| Witzens-Harig, M | 1 |
| Kriegsmann, K | 1 |
| Du, W | 1 |
| Zheng, Z | 1 |
| Han, S | 1 |
| Ma, S | 1 |
| Chen, S | 1 |
| Hsu, C | 1 |
| Tsou, HH | 1 |
| Lin, SJ | 1 |
| Wang, MC | 1 |
| Yao, M | 1 |
| Hwang, WL | 1 |
| Kao, WY | 2 |
| Chiu, CF | 1 |
| Lin, SF | 1 |
| Lin, J | 1 |
| Chang, CS | 1 |
| Tien, HF | 1 |
| Liu, TW | 1 |
| Chen, PJ | 1 |
| Cheng, AL | 2 |
| Zhao, Q | 1 |
| Liu, HP | 1 |
| Gu, YJ | 1 |
| Cong, WM | 1 |
| Wei, Z | 1 |
| Zou, S | 1 |
| Li, F | 1 |
| Cheng, Z | 1 |
| Li, J | 2 |
| Wang, C | 1 |
| Chen, F | 1 |
| Cao, J | 1 |
| Cheng, Y | 1 |
| Masarone, M | 1 |
| De Renzo, A | 1 |
| La Mura, V | 1 |
| Sasso, FC | 1 |
| Romano, M | 1 |
| Signoriello, G | 1 |
| Rosato, V | 1 |
| Perna, F | 1 |
| Pane, F | 1 |
| Persico, M | 1 |
| Topaloğlu, S | 1 |
| Çalık, A | 1 |
| Kalaycı, O | 1 |
| Çeşmecioğlu, E | 1 |
| Çobanoğlu, Ü | 1 |
| Uzun, Y | 1 |
| Silverton, A | 1 |
| Gunthel, C | 1 |
| Adamski, M | 1 |
| Mosunjac, M | 1 |
| Nguyen, ML | 1 |
| Ludwig, E | 1 |
| Pariente, A | 1 |
| Zhao, P | 1 |
| Qu, Z | 1 |
| Ayana, DA | 1 |
| Jiang, Y | 1 |
| Ishihara, T | 1 |
| Kanagawa, M | 1 |
| Koyama, J | 1 |
| Hasegawa, K | 1 |
| Suzuki, T | 1 |
| Hirayama, Y | 1 |
| Terui, T | 1 |
| Huang, H | 1 |
| Li, X | 3 |
| Zhu, J | 2 |
| Ye, S | 1 |
| Zhang, H | 1 |
| Wang, W | 1 |
| Wu, X | 1 |
| Peng, J | 1 |
| Xu, B | 1 |
| Lin, Y | 1 |
| Cao, Y | 1 |
| Li, H | 2 |
| Lin, S | 1 |
| Liu, Q | 1 |
| Lin, T | 1 |
| Elbedewy, TA | 1 |
| Elashtokhy, HE | 1 |
| Rabee, ES | 1 |
| Kheder, GE | 1 |
| Guo, W | 1 |
| Zhang, W | 1 |
| Liu, C | 1 |
| Song, Y | 1 |
| Bai, O | 1 |
| Habib, G | 1 |
| Nashashibi, M | 1 |
| Siraj, F | 1 |
| Dalal, V | 1 |
| Khan, AA | 1 |
| Jain, D | 1 |
| Liu, WP | 1 |
| Wang, XP | 1 |
| Zheng, W | 1 |
| Ping, LY | 1 |
| Zhang, C | 1 |
| Wang, GQ | 1 |
| Song, YQ | 1 |
| Yan, TM | 1 |
| He, CX | 1 |
| Hua, BL | 1 |
| Li, L | 1 |
| Jin, HZ | 1 |
| Liu, YH | 1 |
| Zuo, YG | 1 |
| Castelino, FV | 1 |
| Wasfy, JH | 1 |
| Collier, D | 1 |
| Ueda, Y | 1 |
| Marusawa, H | 1 |
| Ichinohe, T | 1 |
| Kadowaki, N | 1 |
| Uchiyama, T | 2 |
| Chiba, T | 1 |
| Tian, J | 1 |
| Wu, J | 1 |
| He, Q | 1 |
| Han, F | 1 |
| Li, Q | 1 |
| Chen, Y | 1 |
| Ni, Q | 1 |
| Chen, J | 1 |
| Halfon, P | 1 |
| Retornaz, F | 1 |
| Mathieu, D | 1 |
| Helbert, T | 1 |
| Philibert, P | 1 |
| Pégliasco, H | 1 |
| Uchiyama, M | 1 |
| Tamai, Y | 1 |
| Ikeda, T | 1 |
| Stange, MA | 1 |
| Tutarel, O | 1 |
| Pischke, S | 1 |
| Schneider, A | 1 |
| Strassburg, CP | 1 |
| Becker, T | 1 |
| Barg-Hock, H | 1 |
| Bastürk, M | 1 |
| Wursthorn, K | 1 |
| Cornberg, M | 1 |
| Ott, M | 1 |
| Greten, TF | 1 |
| Manns, MP | 1 |
| Wedemeyer, H | 1 |
| Manzia, TM | 1 |
| Di Paolo, D | 1 |
| Sforza, D | 1 |
| Toti, L | 1 |
| Angelico, R | 1 |
| Brega, A | 1 |
| Angelico, M | 1 |
| Tisone, G | 1 |
| Lin, Q | 1 |
| Dong, M | 1 |
| Wen, JY | 1 |
| Wei, L | 1 |
| Ma, XK | 1 |
| Chen, ZH | 1 |
| Wu, XY | 1 |
| Ramsoekh, D | 1 |
| Metselaar, HJ | 1 |
| de Man, RA | 3 |
| Zurawska, U | 1 |
| Hicks, LK | 1 |
| Woo, G | 1 |
| Bell, CM | 1 |
| Krahn, M | 1 |
| Chan, KK | 1 |
| Feld, JJ | 1 |
| Hay, AE | 1 |
| Meyer, RM | 1 |
| Simon, Z | 1 |
| Illés, A | 1 |
| Miltényi, Z | 1 |
| Magyari, F | 1 |
| Váróczy, L | 1 |
| Péter, N | 1 |
| Gergely, L | 1 |
| Arkachaisri, T | 1 |
| Nakamura, T | 1 |
| Tomoda, K | 1 |
| Yamamura, Y | 1 |
| Tsukano, M | 1 |
| Honda, I | 1 |
| Iyama, K | 1 |
| Gupta, V | 1 |
| Kamel-Reid, S | 1 |
| Minden, MD | 1 |
| Lipton, JH | 1 |
| Brandwein, J | 1 |
| Messner, HA | 1 |
| Ohmoto, K | 1 |
| Tsuduki, M | 1 |
| Yamamoto, S | 1 |
| Simpson, ND | 1 |
| Simpson, PW | 1 |
| Ahmed, AM | 1 |
| Nguyen, MH | 1 |
| Garcia, G | 1 |
| Keeffe, EB | 1 |
| Ahmed, A | 1 |
| Nuevo, H | 1 |
| Nascimento-Carvalho, CM | 1 |
| Athayde-Oliveira, CP | 1 |
| Lyra, I | 1 |
| Moreira, LM | 1 |
| Guillevin, L | 7 |
| Mahr, A | 1 |
| Cohen, P | 2 |
| Larroche, C | 1 |
| Queyrel, V | 1 |
| Loustaud-Ratti, V | 1 |
| Imbert, B | 1 |
| Hausfater, P | 1 |
| Roudier, J | 1 |
| Bielefeld, P | 1 |
| Petitjean, P | 1 |
| Smadja, D | 1 |
| Janssen, HL | 1 |
| van Zonneveld, M | 1 |
| van Nunen, AB | 1 |
| Niesters, HG | 1 |
| Schalm, SW | 7 |
| Dai, MS | 1 |
| Chao, TY | 1 |
| Shyu, RY | 1 |
| Liu, TM | 1 |
| Acquatella, G | 1 |
| Insausti, CL | 1 |
| García, R | 1 |
| Gómez, R | 1 |
| Hernández, M | 1 |
| Carneiro, M | 1 |
| Santos, S | 1 |
| Nouel, A | 1 |
| Zell, JA | 1 |
| Yoon, EJ | 1 |
| Ignatius Ou, SH | 1 |
| Hoefs, JC | 1 |
| Chang, JC | 1 |
| Law, JK | 1 |
| Ho, JK | 1 |
| Hoskins, PJ | 1 |
| Erb, SR | 1 |
| Steinbrecher, UP | 1 |
| Yoshida, EM | 1 |
| Nagasaki, A | 1 |
| Taira, N | 1 |
| Tomoyose, T | 1 |
| Miyagi, T | 1 |
| Nakachi, S | 1 |
| Shinzato, O | 1 |
| Hasegawa, H | 1 |
| Takasu, N | 1 |
| Smolej, L | 1 |
| Di Marco, V | 1 |
| De Lisi, S | 1 |
| Li Vecchi, M | 1 |
| Maringhini, S | 1 |
| Barbaria, F | 1 |
| Belot, A | 1 |
| Ranchin, B | 1 |
| Canterino, I | 1 |
| Trepo, C | 5 |
| Dubourg, L | 1 |
| Cochat, P | 1 |
| Yamagata, M | 1 |
| Murohisa, T | 1 |
| Tsuchida, K | 1 |
| Okamoto, Y | 1 |
| Tsunoda, S | 1 |
| Nakamura, M | 1 |
| Kusano, K | 1 |
| Majima, Y | 1 |
| Kuniyoshi, T | 1 |
| Iijima, M | 1 |
| Sugaya, H | 1 |
| Hiraishi, H | 1 |
| Ono, K | 1 |
| Iyama, S | 1 |
| Matsunaga, T | 1 |
| Sato, T | 2 |
| Sato, Y | 1 |
| Okuda, T | 1 |
| Takada, K | 1 |
| Kawano, Y | 1 |
| Hayashi, T | 1 |
| Miyanishi, K | 1 |
| Sagawa, T | 1 |
| Kobune, M | 1 |
| Takimoto, R | 1 |
| Kato, J | 2 |
| Niitsu, Y | 2 |
| Thirot-Bidault, A | 1 |
| Ben Mansour, J | 1 |
| Lambotte, O | 1 |
| Besson, C | 1 |
| Bou-Farah, R | 1 |
| Pallier, C | 1 |
| Buffet, C | 1 |
| Kojima, M | 1 |
| Takeuchi, T | 1 |
| Karasawa, M | 1 |
| Murakami, H | 1 |
| Sato, S | 1 |
| Thalhammer, O | 1 |
| Vercruysse, G | 1 |
| Bletry, O | 1 |
| Bussel, A | 1 |
| Badelon, I | 1 |
| Lesavre, P | 1 |
| Herson, S | 1 |
| Godeau, P | 1 |
| Mistilis, SP | 1 |
| Lam, KC | 1 |
| Auer, IO | 1 |
| Arnold, W | 1 |
| Meyer zum Büschenfelde, KH | 2 |
| Pignata, C | 2 |
| Vajro, P | 4 |
| Troncone, R | 1 |
| Monaco, G | 2 |
| Ciriaco, M | 1 |
| Fitzgerald, JF | 1 |
| Pastore, G | 2 |
| Tannoia, N | 1 |
| Angarano, G | 2 |
| Monno, L | 1 |
| Santantonio, T | 1 |
| Pietrapertosa, A | 1 |
| Malcangi, G | 1 |
| Putignano, A | 1 |
| Schiraldi, O | 2 |
| Johnson, BE | 1 |
| Reed, JS | 1 |
| Gheorghescu, B | 1 |
| Villa, E | 1 |
| Jenkins, P | 1 |
| Portmann, B | 1 |
| Eddleston, AL | 1 |
| Williams, R | 1 |
| Rakela, J | 2 |
| Redeker, AG | 2 |
| Weliky, B | 1 |
| Mayor, GH | 1 |
| Kelly, TJ | 1 |
| Hourani, MR | 1 |
| Patterson, MJ | 1 |
| Tanno, H | 2 |
| Fay, O | 2 |
| Roldán, L | 1 |
| Vorovioff, J | 1 |
| Rudkowski, Z | 1 |
| Wasik, F | 1 |
| Chabudzinska, S | 1 |
| Saraczynska, E | 1 |
| Chossegros, P | 2 |
| Brette, R | 1 |
| Chevallier, P | 1 |
| Vitviski, L | 1 |
| Sepetjan, M | 1 |
| Scullard, GH | 1 |
| Smith, CI | 1 |
| Merigan, TC | 1 |
| Robinson, WS | 1 |
| Gregory, PB | 1 |
| Paradinas, FJ | 1 |
| Davies, DR | 1 |
| Supran, EM | 1 |
| Viola, L | 1 |
| Marigold, JH | 1 |
| Boroń, P | 1 |
| Szpakowicz, T | 1 |
| Borzuchowska, A | 1 |
| Prokopowicz, D | 1 |
| Nadowska, K | 1 |
| Bobrowska, E | 1 |
| Boroń-Kaczmarska, A | 1 |
| Rzewnicki, I | 1 |
| Miegoć, H | 1 |
| Szczotka, W | 1 |
| Sawaryn, T | 1 |
| Machalska, M | 1 |
| Mossor, K | 1 |
| Honkoop, P | 1 |
| Heijtink, RA | 1 |
| Cohard, M | 2 |
| Poynard, T | 1 |
| Mathurin, P | 1 |
| Zarski, JP | 3 |
| Langrehr, JM | 1 |
| Lemmens, HP | 1 |
| Keck, H | 1 |
| Lohmann, R | 1 |
| Knoop, M | 1 |
| Neumann, U | 1 |
| Müller, AR | 1 |
| Platz, KP | 1 |
| Kling, N | 1 |
| Hopf, U | 1 |
| Fei, GZ | 1 |
| Sylvan, SP | 1 |
| Hellström, UB | 1 |
| Yao, GB | 1 |
| Gayraud, M | 3 |
| Casassus, P | 2 |
| Causse, X | 2 |
| Cougnard, J | 1 |
| Reichen, J | 1 |
| Bianchi, L | 1 |
| Frei, PC | 1 |
| Malé, PJ | 1 |
| Lavanchy, D | 1 |
| Schmid, M | 1 |
| Utili, R | 2 |
| Sagnelli, E | 2 |
| Gaeta, GB | 1 |
| Galanti, B | 2 |
| Nardiello, S | 1 |
| Felaco, FM | 1 |
| Pasquale, G | 1 |
| Marrone, A | 1 |
| Aprea, L | 2 |
| Pizzella, T | 1 |
| Petit, MA | 1 |
| Zoulim, F | 2 |
| Berthillon, P | 1 |
| Capel, F | 1 |
| Dauguet, C | 1 |
| Ferrari, C | 1 |
| Ras, E | 1 |
| Michaeli, J | 2 |
| Rosenmann, E | 1 |
| Popovtzer, MM | 2 |
| Polliack, A | 1 |
| Shouval, D | 2 |
| Lok, AS | 5 |
| Fang, JW | 1 |
| Lau, JY | 3 |
| Davis, GL | 3 |
| Romero, R | 1 |
| Kleinman, RE | 1 |
| Godinot, H | 1 |
| Chevallier, M | 1 |
| Meschiewitz, C | 1 |
| Albrecht, J | 2 |
| Chung, HT | 3 |
| Lai, CL | 4 |
| Perrillo, RP | 6 |
| Lhote, F | 2 |
| Jarrousse, B | 2 |
| Lortholary, O | 1 |
| Thibult, N | 1 |
| Gómez Camacho, F | 1 |
| Poyato González, A | 1 |
| Vignote Alguacil, ML | 1 |
| de La Mata García, M | 1 |
| González Fernández, RA | 1 |
| López Rubio, F | 1 |
| Marchal Molina, T | 1 |
| Miño Fugarolas, G | 1 |
| Hsieh, H | 1 |
| Chen, CH | 1 |
| Huang, HF | 1 |
| Tseng, YJ | 1 |
| Lopez-Alcorocho, JM | 1 |
| Cabrerizo, M | 1 |
| Bartolome, J | 1 |
| Cotonat, T | 1 |
| Carreño, V | 1 |
| Tedesco, M | 1 |
| Fontanella, A | 3 |
| De Vincenzo, A | 1 |
| Vecchione, R | 1 |
| Ammendola, R | 1 |
| Terracciano, LM | 1 |
| Novissimo, A | 1 |
| Vegnente, A | 2 |
| Wong, GC | 1 |
| Tan, P | 1 |
| Goh, YT | 1 |
| Ng, HS | 1 |
| Chong, R | 1 |
| Lee, LH | 1 |
| Haanen, JB | 1 |
| Bieger, R | 1 |
| van't Wout, JW | 1 |
| Itoh, Y | 1 |
| Okanoue, T | 1 |
| Sakamoto, S | 1 |
| Nishioji, K | 1 |
| Kashima, K | 1 |
| Kawanishi, J | 1 |
| Kogawa, K | 1 |
| Ohya, M | 1 |
| Sakamaki, S | 1 |
| Narváez, J | 1 |
| Rodriguez-Moreno, J | 1 |
| Martinez-Aguilá, MD | 1 |
| Clavaguera, MT | 1 |
| Akiyama, J | 1 |
| Hayashi, S | 1 |
| Masaki, N | 1 |
| Fukushima, K | 1 |
| Matsukawa, M | 1 |
| Yamato, S | 1 |
| Shoda, R | 1 |
| Muraoka, R | 1 |
| Shimojo, E | 1 |
| Umeda, N | 1 |
| Togawa, A | 1 |
| Mensing, HJ | 1 |
| Suárez García, E | 1 |
| Romero Gómez, M | 1 |
| Grande Santamaría, L | 1 |
| Gupta, S | 1 |
| Piraka, C | 1 |
| Jaffe, M | 1 |
| Rossi, G | 1 |
| Pelizzari, A | 1 |
| Motta, M | 1 |
| Puoti, M | 1 |
| Shtalrid, M | 1 |
| Haran, M | 1 |
| Klepfish, A | 1 |
| Lurie, Y | 1 |
| Malnick, S | 1 |
| Feist, D | 1 |
| Müller, R | 1 |
| Vogten, AJ | 1 |
| Summerskill, WH | 4 |
| Gitnick, GL | 2 |
| Smith, JL | 1 |
| Murphy, BL | 1 |
| Maynard, JE | 1 |
| Dentico, P | 1 |
| Buongiorno, R | 1 |
| Tursi, A | 1 |
| Loria, MP | 1 |
| Mozes, MF | 1 |
| Ascher, NL | 1 |
| Balfour, HH | 1 |
| Simmons, RL | 1 |
| Najarian, JS | 1 |
| Cocchi, P | 1 |
| Silenzi, M | 1 |
| Salvi, G | 1 |
| Calabri, G | 1 |
| Czaja, AJ | 3 |
| Strohmeyer, G | 1 |
| Thier, W | 1 |
| Orbuch, SJ | 1 |
| Findor, JA | 1 |
| Darnis, F | 1 |
| Poupon, R | 1 |
| D'Escatha, P | 1 |
| Blaustein, M | 1 |
| Najman, A | 1 |
| Boizard, B | 1 |
| Wautier, JL | 1 |
| Henon, P | 1 |
| Reviron, J | 1 |
| Laverdant, C | 1 |
| Molinié, C | 1 |
| Essioux, H | 1 |
| Daly, JP | 1 |
| Elveback, LR | 1 |
| Sherlock, S | 2 |
| Patten, BM | 1 |
| Shabot, JM | 1 |
| Alperin, J | 1 |
| Dodson, RF | 1 |
| Wands, JR | 1 |
| Perrotto, JL | 1 |
| Alpert, E | 1 |
| Isselbacher, KJ | 1 |
| Laursen, HB | 1 |
| Zaentz, DS | 1 |
| Krantz, SB | 1 |
| Sears, DA | 1 |
| Pelikán, V | 1 |
| Seidlová, V | 1 |
| Sánová, J | 1 |
| Komenda, S | 1 |
| Minuk, GY | 1 |
| German, GB | 1 |
| Bernstein, C | 1 |
| Benarroch, A | 1 |
| Gauthier, T | 1 |
| Sekla, L | 1 |
| Cianciara, J | 3 |
| Gładysz, A | 1 |
| Juszczyk, J | 1 |
| Laskus, T | 3 |
| Mach, G | 1 |
| Simon, K | 1 |
| Loch, T | 3 |
| Machaj, A | 1 |
| Soh, LT | 1 |
| Ang, PT | 1 |
| Sng, I | 1 |
| Chua, EJ | 1 |
| Ong, YW | 1 |
| Kuhns, M | 2 |
| McNamara, A | 1 |
| Mason, A | 1 |
| Campbell, C | 1 |
| Perrillo, R | 1 |
| Robson, SC | 1 |
| Brice, E | 1 |
| van Rensburg, C | 1 |
| Kannemeyer, J | 1 |
| Hift, RJ | 1 |
| Kirsch, RE | 1 |
| Giusti, G | 1 |
| Ruggiero, G | 1 |
| Piccinino, F | 1 |
| Adinolfi, LE | 1 |
| Cesaro, G | 1 |
| Digilio, L | 1 |
| Wu, PC | 3 |
| Leung, EK | 2 |
| Wong, LS | 2 |
| Ma, OC | 1 |
| Lauder, IJ | 1 |
| Ng, CP | 1 |
| Senderos Aguirre, B | 1 |
| Arranz Sanjuan, RM | 1 |
| Cadenas Gallego, M | 1 |
| Marañón Pardillo, R | 1 |
| Padilla Esteban, ML | 1 |
| García Fernández, EJ | 1 |
| Leung, NW | 1 |
| Leung, JC | 1 |
| Tam, JS | 1 |
| Lau, JT | 1 |
| Lai, KN | 1 |
| Peters, M | 1 |
| Brahm, J | 1 |
| Hurtado, C | 1 |
| Polito, C | 1 |
| La Manna, A | 1 |
| Cartiglia, ML | 1 |
| Bonomo, G | 1 |
| Del Gado, R | 1 |
| Silva, MO | 1 |
| Reddy, KR | 1 |
| Jeffers, LJ | 1 |
| Hill, M | 1 |
| Schiff, ER | 2 |
| de Moura, MC | 1 |
| Velosa, J | 1 |
| Pinto, HC | 1 |
| Herzenberg, H | 1 |
| Paul, RG | 1 |
| Roodman, ST | 1 |
| Campbell, CR | 3 |
| Bodicky, CJ | 3 |
| Lin, HJ | 1 |
| Lau, JN | 1 |
| Flok, AS | 1 |
| Wong, LK | 1 |
| Leung, MP | 1 |
| Yeung, CY | 1 |
| Fevery, J | 1 |
| Elewaut, A | 1 |
| Michielsen, P | 1 |
| Nevens, F | 1 |
| Van Eyken, P | 1 |
| Adler, M | 1 |
| Desmet, V | 1 |
| Perez, V | 1 |
| Villamil, F | 1 |
| Fung, YL | 1 |
| Kuhns, MC | 2 |
| Spagliardi, E | 1 |
| Longo, A | 1 |
| Blanco, GF | 1 |
| Ruggeri, C | 1 |
| Buscaglia, M | 1 |
| Torelli, P | 1 |
| Bodenheimer, HC | 1 |
| Lindsay, K | 1 |
| Payne, J | 1 |
| Dienstag, JL | 1 |
| O'Brien, C | 1 |
| Tamburro, C | 1 |
| Jacobson, IM | 1 |
| Sampliner, R | 1 |
| Feit, D | 1 |
| Lefkowitch, J | 1 |
| Meschievitz, C | 1 |
| Sanghvi, B | 1 |
| Gibas, A | 1 |
| Slusarczyk, J | 2 |
| Pinto, PC | 1 |
| Hu, E | 1 |
| Bernstein-Singer, M | 1 |
| Pinter-Brown, L | 1 |
| Govindarajan, S | 1 |
| Thomas, HC | 1 |
| Lever, AM | 1 |
| Scully, LJ | 1 |
| Pignatelli, M | 1 |
| Jafri, SM | 1 |
| Regenstein, FG | 2 |
| Sanders, GE | 1 |
| Sunwoo, YC | 1 |
| Qin, SM | 1 |
| Chen, LY | 1 |
| Guo, YD | 1 |
| Raz, E | 1 |
| Brezis, M | 1 |
| Gazitt, Y | 1 |
| Nuzzo, V | 1 |
| Ciccimarra, F | 1 |
| Merrouche, Y | 1 |
| Royer, I | 1 |
| Léon, A | 1 |
| Baudelot, J | 1 |
| Gu, CH | 1 |
| He, CQ | 1 |
| Wang, GX | 1 |
| Peters, MG | 1 |
| DeSchryver-Kecskemeti, K | 1 |
| Hess, G | 1 |
| Manns, M | 1 |
| Hütteroth, TH | 1 |
| Luo, KX | 1 |
| Liang, CS | 1 |
| Lin, RH | 1 |
| Wood, JR | 1 |
| Taswell, HF | 2 |
| Ludwig, J | 2 |
| Chase, R | 1 |
| Eichberg, JW | 1 |
| Seeff, LB | 1 |
| Lawlor, DL | 1 |
| Buskell-Bales, Z | 1 |
| Ishak, K | 1 |
| Hoofnagle, JH | 1 |
| Goldstein, AL | 1 |
| Langloss, JM | 1 |
| Orso, G | 1 |
| D'Antonio, A | 1 |
| Greco, L | 1 |
| Loffredo, G | 1 |
| Oggero, V | 1 |
| Buffolano, W | 1 |
| Go, VL | 1 |
| Renger, F | 1 |
| Kissling, M | 1 |
| Speck, B | 1 |
| Koff, RS | 1 |
| Widrich, WC | 1 |
| Robbins, AH | 1 |
| Van Slyck, EJ | 1 |
| Rebuck, JW | 1 |
| Bowie, EJ | 1 |
| Maldonado, E | 1 |
| Brown, AL | 1 |
| Didisheim, P | 1 |
| Owen, CA | 1 |
| Boyer, JL | 1 |
| Klatskin, G | 2 |
| Nelson, RS | 1 |
| Lanza, FL | 1 |
| Aboul-Enein, MI | 1 |
| Kotb, A | 1 |
| Mohieddin, O | 1 |
| Torisu, M | 2 |
| Yokoyama, T | 2 |
| Kohler, PF | 2 |
| Durst, AL | 1 |
| Martineau, G | 2 |
| Schroter, G | 2 |
| Amemiya, H | 2 |
| Groth, CG | 1 |
| Starzl, TE | 2 |
| Rogers, AI | 1 |
| Penn, I | 1 |
| Palmer, W | 1 |
| Halgrimson, CG | 1 |
| Putnam, CW | 1 |
| Barreto, VT | 1 |
| Lange, HF | 1 |
| Shreiber, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open, Randomized Controlled Clinical Trial to Compare the Prophylactic Use or Preemptive Use of an Anti-viral Drug Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B Carriers[NCT02777814] | Phase 2 | 50 participants (Anticipated) | Interventional | 2015-05-01 | Recruiting | ||
| An Open, Randomized Controlled Clinical Trial to Compare the Prophylactic Use or Preemptive Use of an Anti-viral Drug Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers[NCT02777801] | Phase 2 | 50 participants (Anticipated) | Interventional | 2015-06-30 | Recruiting | ||
| A Prospective , Multicenter, Randomized Phase III Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients[NCT01793844] | 732 participants (Anticipated) | Observational | 2008-01-31 | Recruiting | |||
| A Study on the Viral Kinetics of Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in HBeAg Positive Chronic Hepatitis B[NCT00226447] | Phase 2 | 30 participants | Interventional | 2002-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for prednisone and Hepatitis B
| Article | Year |
|---|---|
Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Biopsy; China; Collagen Type VII; Cyclosporine; Epidermo | 2017 |
[Immunologic changes in diffuse large B-cell lymphomas after rituximab-CHOP treatment: own data and review of the literature].
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Serum sickness and hepatitis B vaccine including review of the literature.
Topics: Adolescent; Cetirizine; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Vaccines; Humans | 2002 |
Polyarteritis nodosa limited to calf muscles: a case report and review of the literature.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Carrier State; Fasciitis; Female; Hepatitis B; Humans; Magn | 2003 |
Thrombocytopenic purpura after hepatitis B vaccine: case report and review of the literature.
Topics: Administration, Oral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Vaccines; Humans; Infant; | 2004 |
[Fatal liver failure after hepatitis B reactivation following chemotherapy for lymphoma in a patient with only anti-HBc antibody and review of the literature].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; | 2007 |
[Therapy of chronic hepatitis (author's transl)].
Topics: Autoimmune Diseases; Azathioprine; Chloroquine; Chronic Disease; Diagnosis, Differential; Hepatitis; | 1981 |
Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.
Topics: Alanine Transaminase; Chronic Disease; Combined Modality Therapy; DNA, Viral; Follow-Up Studies; Hep | 1994 |
Antiviral therapy of the Asian patient with chronic hepatitis B.
Topics: Adult; Child; China; Clinical Trials as Topic; Female; Hepatitis B; Hepatitis, Chronic; Humans; Inte | 1993 |
Interferon in the management of chronic hepatitis B.
Topics: Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Hepatitis B; Humans; Interfero | 1993 |
Chronic hepatitis. To treat or not to treat?
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Hepatitis; Hepatitis B; Humans; Middl | 1978 |
[Chronic hepatitis].
Topics: Azathioprine; Hepatitis; Hepatitis B; Humans; Liver Cirrhosis; Prednisolone; Prednisone; Prognosis | 1976 |
Alpha-interferon therapy for chronic hepatitis B virus infection in children and Oriental patients.
Topics: Adult; Child; Child, Preschool; Hepatitis B; Hepatitis, Chronic; Hong Kong; Humans; Interferon Type | 1991 |
Is there an alternative to alpha-interferon in chronic hepatitis B?
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Drug Therap | 1991 |
[Rare primary hepatic neoplasms. Our experience in 2 cases: a primary lymphoma and a leiomyosarcoma of the liver].
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cycloph | 1990 |
Approaches to the treatment of hepatitis B virus and delta-related liver disease.
Topics: Adult; Animals; Carrier State; Hepatitis B; Hepatitis B Antibodies; Hepatitis D; Hepatitis, Chronic; | 1986 |
Treatment of chronic hepatitis B, delta related liver disease and non-A non-B hepatitis.
Topics: Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis, Viral, Human; Humans; Interferons; Prednisone; Vid | 1989 |
Therapeutic considerations in selected forms of acute and chronic liver disease.
Topics: Acute Disease; Age Factors; Alcoholism; Azathioprine; Chemical and Drug Induced Liver Injury; Chroni | 1971 |
35 trials available for prednisone and Hepatitis B
| Article | Year |
|---|---|
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Topics: Adult; Carrier State; China; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combina | 2009 |
Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Drug Administration Schedul | 2004 |
Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease Progres | 2004 |
Polyarteritis nodosa and Churg-Strauss syndrome. An internist's view.
Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Churg-Strauss Syndrome; Cyclophosphamide; He | 1993 |
A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group.
Topics: Adult; Alanine Transaminase; Biomarkers; Drug Therapy, Combination; Female; Follow-Up Studies; Hepat | 1994 |
Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. Swiss Association for the Study of the Liver.
Topics: Adolescent; Adult; Aged; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B vir | 1994 |
Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.
Topics: Adolescent; Child; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepa | 1994 |
PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B.
Topics: Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Immun | 1994 |
Re-evaluation of alpha-interferon treatment of chronic hepatitis B using polymerase chain reaction.
Topics: Base Sequence; Chronic Disease; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B v | 1993 |
[Comparison of 2 treatment strategies with prednisone and interferon in chronic hepatitis B].
Topics: Adolescent; Adult; Analysis of Variance; Anti-Inflammatory Agents; Antiviral Agents; Child; Chronic | 1996 |
Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon.
Topics: Alanine Transaminase; Anti-Inflammatory Agents; Antiviral Agents; Base Sequence; Genetic Variation; | 1995 |
Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepa | 1996 |
Treatment of polyarteritis nodosa and Churg-Strauss syndrome: indications of plasma exchanges.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Antiviral Agents; Cause of | 1994 |
[Apropos of corticoid therapy of acute viral hepatitis at the early phase].
Topics: Adrenal Cortex Hormones; Adult; Hepatitis A; Hepatitis B; Hepatitis, Viral, Human; Humans; Prednison | 1978 |
Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.
Topics: Adult; Age Factors; Azathioprine; Chronic Disease; Clinical Trials as Topic; Female; Hepatitis; Hepa | 1976 |
A pilot study of steroid withdrawal followed by oral acyclovir in the treatment of chronic type B hepatitis.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Alanine Transaminase; Chemical and Drug Induced | 1992 |
[Treatment of chronic hepatitis B with interferon alpha (Wellferon) with and without previous corticosteroid therapy -- results of a multicenter, double blind study].
Topics: Adult; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis B; Humans; Interferon-alpha | 1992 |
Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
Topics: Adolescent; Adult; Aged; Female; Hepatitis B; Hepatitis, Chronic; Humans; Interferon alpha-2; Interf | 1992 |
Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial.
Topics: Adolescent; Child; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Hepatitis, Chr | 1992 |
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis B; Humans | 1992 |
Alpha-interferon therapy for chronic hepatitis B virus infection in children and Oriental patients.
Topics: Adult; Child; Child, Preschool; Hepatitis B; Hepatitis, Chronic; Hong Kong; Humans; Interferon Type | 1991 |
Treatment of polyarteritis nodosa and Churg-Strauss angiitis: indications of plasma exchange. Results of three prospective trials in 162 patients. The Cooperative Study Group for the Study of Polyarteritis Nodosa.
Topics: Adult; Aged; Churg-Strauss Syndrome; Combined Modality Therapy; Cyclophosphamide; Female; Hepatitis | 1990 |
Interferon alfa-2b for chronic hepatitis B.
Topics: Chronic Disease; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon- | 1991 |
HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B.
Topics: Alanine Transaminase; Cells, Cultured; Chronic Disease; Cryopreservation; Hepatitis B; Histocompatib | 1991 |
Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
Topics: Adolescent; Carrier State; Child; Child, Preschool; China; DNA, Viral; Double-Blind Method; Female; | 1991 |
Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study.
Topics: Belgium; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Hepatitis B; Humans; Inter | 1990 |
Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis.
Topics: Adult; Alanine Transaminase; Biomarkers; Chronic Disease; Drug Administration Schedule; Female; Hepa | 1990 |
Alpha-interferon treatment in Chinese patients with chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Biomarkers; Child, Preschool; China; Chronic Disease; Drug Therapy, Com | 1990 |
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
Topics: Adult; Chronic Disease; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface | 1990 |
The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication.
Topics: Adult; Arabinonucleotides; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hepatitis B; | 1986 |
Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
Topics: Adult; Arabinonucleotides; Clinical Trials as Topic; Drug Administration Schedule; Drug Synergism; F | 1985 |
[Therapeutic effects of polyI:C and prednisone withdrawal followed by polyI:C on chronic type B hepatitis--results of two double-blind randomized trials].
Topics: Adult; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis B; Hepatit | 1989 |
Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
Topics: Adult; Alanine Transaminase; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; D | 1988 |
Inefficacy of immunosuppressive treatment in HBSAg-positive, delta-negative, moderate chronic active hepatitis in children.
Topics: Azathioprine; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Female; | 1985 |
143 other studies available for prednisone and Hepatitis B
| Article | Year |
|---|---|
Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Hepatitis A; Hepatitis B; Hepatitis B Antibodies; Hepatit | 2022 |
Recombinant human thrombopoietin increases platelet count in severe thrombocytopenic patients with hepatitis B-related cirrhosis: Multicentre real-world observational study.
Topics: Hepatitis B; Humans; Liver Cirrhosis; Platelet Count; Prednisone; Recombinant Proteins; Splenomegaly | 2022 |
Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Diff | 2020 |
Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan - a population-based study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubici | 2021 |
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antineoplastic Agents, Immunological; Antineop | 2021 |
Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cohort Studi | 2017 |
Combined prednisone and levothyroxine improve treatment of severe thrombocytopenia in hepatitis B with compensatory cirrhosis accompanied by subclinical and overt hypothyroidism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Therapy, Combination; Fem | 2018 |
Diffuse large B-cell lymphoma with concurrent hepatitis B virus infection in the MabThera era: Unique clinical features and worse outcomes.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2018 |
Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclopho | 2019 |
HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review.
Topics: Aged; DNA, Viral; Hepatitis B; Humans; Kidney Glomerulus; Male; Nephrotic Syndrome; Prednisone; Recu | 2013 |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antin | 2014 |
[Clinicopathological and survival features of primary hepatic lymphoma: an analysis of 35 cases].
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antigens, CD20; Antineoplastic Combined Chemotherapy Pr | 2013 |
HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; China; Cyclo | 2014 |
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Fibrosing cholestatic hepatitis after methotrexate and prednisone therapy for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Chemical and Drug Induced Liver Injury; Cholest | 2014 |
Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; Antibodies, Monoclonal, Murine-De | 2014 |
HBV reactivation in immunosuppressed patients: prevention or containment?
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2014 |
[Risk of reactivation of hepatitis B in patients with the lymphoma HBsAg negative , anti-HBc positive treated with rituximab-CHOP].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2014 |
Frequency of CD4+CXCR5+ TFH cells in patients with hepatitis b virus-associated membranous nephropathy.
Topics: Adult; CD4 Antigens; Cells, Cultured; Cytokines; Disease Progression; Female; Follow-Up Studies; Glo | 2014 |
B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibody.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2014 |
Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
Topics: Adult; Aged; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Cross-Sectional Stud | 2015 |
Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2015 |
Tenofovir-induced severe hepatitis in occult hepatitis B reactivation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Ag | 2015 |
Hepatosplenic T-cell lymphoma with coexistent hepatitis B infection: a rare clinicopathologic entity.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Biopsy; Cyclophosphamide; D | 2016 |
Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protoco | 2016 |
A 36-year-old man with paresthesias and a headache.
Topics: Adult; Amlodipine; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Guanine; Headache; He | 2008 |
Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cervix Uteri; Cyclophospham | 2009 |
Virus-Associated Hemophagocytic Syndrome related to acute CMV and HBV sexual co-infection: a case report.
Topics: Anti-Inflammatory Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Hepatitis B; Hepatiti | 2009 |
Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chemoprevention; Cyclophosphamide; | 2010 |
Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results.
Topics: Azathioprine; Cyclosporine; Graft Survival; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Immun | 2010 |
Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma.
Topics: Acute Disease; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemothe | 2010 |
[Reactivation of hepatitis B infection due to glucocorticoids].
Topics: Aged; Female; Glucocorticoids; Hepatitis B; Hepatitis B virus; Humans; Male; Middle Aged; Prednisone | 2011 |
Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cost-B | 2012 |
Hepatitis B, rituximab, screening, and prophylaxis: effectiveness and cost effectiveness.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit | 2012 |
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; D | 2003 |
Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hepatitis B; He | 2003 |
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxo | 2003 |
Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.
Topics: Adult; Amino Acid Sequence; Animals; Antiviral Agents; Combined Modality Therapy; Genome, Viral; Hep | 2004 |
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Topics: Adult; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigen | 2004 |
Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2005 |
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.
Topics: Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplasti | 2005 |
[Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy].
Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carrier State; CD8-Po | 2006 |
Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Hepat | 2007 |
Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Follow-Up Studies; | 2006 |
Hypertensive crisis, hepatitis B virus and polyarteritis nodosa in a child.
Topics: Angiography; Antiviral Agents; Child, Preschool; Glucocorticoids; Hepatitis B; Hepatitis B virus; Hu | 2007 |
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2007 |
[Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma].
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Comb | 2007 |
Primary cutaneous CD5+ marginal zone B-cell lymphoma resembling the plasma cell variant of Castleman's disease. Case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Castleman Disease; CD5 Antigens; | 2007 |
[Congenital hepatitis].
Topics: Biopsy; Diagnosis, Differential; Female; Hepatitis; Hepatitis B; Humans; Infant; Liver; Male; Matern | 1966 |
[Value of plasma exchange in necrotizing angeitis. 11 cases].
Topics: Adolescent; Adult; Antigen-Antibody Complex; Arteritis; Cyclophosphamide; Female; Follow-Up Studies; | 1982 |
Management of chronic hepatitis. Part two: treatment.
Topics: Azathioprine; Chronic Disease; gamma-Globulins; Hepatitis B; Hepatitis, Viral, Human; Humans; Liver | 1980 |
[Therapy of chronic hepatitis (author's transl)].
Topics: Azathioprine; Chronic Disease; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepat | 1980 |
Immunoregulatory T subsets in chronic active viral hepatitis: characterization by monoclonal antibodies.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Child; Child, Preschool; Female; Hepatitis B; Hepa | 1983 |
Chronic hepatitis.
Topics: Autoimmune Diseases; Azathioprine; Child; Hepatitis B; Hepatitis, Chronic; Humans; Immunosuppressive | 1984 |
Chronic viral hepatitis in thalassemic liver disease. A long-term study in patients with acute hepatitis with nontransfusion-dependent thalassemia minor.
Topics: Acute Disease; Blood Transfusion; Hepatitis A; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis | 1983 |
Prolongation of the prodrome to acute hepatitis B infection by corticosteroids.
Topics: Female; Hepatitis B; Humans; Immunosuppression Therapy; Middle Aged; Prednisone; Serum Sickness | 1983 |
Short-term prednisone in chronic hepatitis B.
Topics: Hepatitis B; Humans; Prednisone | 1984 |
Evidence for hepatitis B and other virus infection in HBsAg-negative chronic active hepatitis.
Topics: Adult; Azathioprine; Chronic Disease; Female; Fluorescent Antibody Technique; Hepatitis; Hepatitis B | 1980 |
Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.
Topics: Adult; Alanine Transaminase; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B e Antigens; Hepat | 1983 |
Intermittent hepatitis B surface antigenuria in a renal transplant recipient.
Topics: Adult; Azathioprine; Carrier State; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immun | 1980 |
[Should chronic active viral hepatitis be treated with drugs or not?].
Topics: Adjuvants, Immunologic; Antiviral Agents; Azathioprine; Carrier State; Hepatitis B; Hepatitis B Surf | 1981 |
[Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; Azathioprine; Child; Child, Preschool; Chronic | 1982 |
[Gianotti-Crosti syndrome in the course of juvenile acute hepatitis B infection].
Topics: Acrodermatitis; Child, Preschool; Exanthema; Female; Hepatitis B; Humans; Infant; Prednisone; Syndro | 1981 |
[Prognostic value of HBe antigen and anti-HBe antibody in viral hepatitis B (author's transl)].
Topics: Antibodies, Viral; Azathioprine; Chronic Disease; Hepatitis B; Hepatitis B Antibodies; Hepatitis B A | 1981 |
Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
Topics: Adult; Aspartate Aminotransferases; Azathioprine; Chronic Disease; DNA-Directed DNA Polymerase; Fema | 1981 |
Histopathology and localization of viral antigens in the liver of HBsAg positive homosexuals.
Topics: Azathioprine; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Homosexuality; H | 1981 |
[Critical analysis of complex therapeutic methods in acute hepatic insufficiency with encephalopathy in the course of viral hepatitis].
Topics: Adult; Aged; Evaluation Studies as Topic; Exchange Transfusion, Whole Blood; Female; Heparin; Hepati | 1980 |
[Comparative evaluation of the results of treatment of viral hepatitis with glucocorticoids and duodenal decompressing drainage with administration of 5% glucose solution].
Topics: Adult; Aged; Drainage; Duodenum; Evaluation Studies as Topic; Female; Glucose; Hepatitis B; Humans; | 1980 |
Treatment of chronic active hepatitis. Good news and bad news.
Topics: Female; Hepatitis; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis, Viral, Human; Humans; Male; | 1981 |
Hepatitis B reactivation after lamivudine.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e | 1995 |
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; DNA, Viral; Female; | 1995 |
Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Child; Chronic Disease; Drug Therapy, Combination; Hepatitis | 1995 |
Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma.
Topics: Breast Neoplasms; Fatal Outcome; Female; Gene Expression Regulation, Viral; Glomerulonephritis, Memb | 1993 |
HIV-induced HBV breakthrough during interferon-alpha therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alanine Transaminase; Hepatitis B; Hepatitis B virus; Hum | 1993 |
Thrombocytopenia associated with acute hepatitis B infection.
Topics: Alanine Transaminase; Bone Marrow Examination; Child, Preschool; Diagnosis, Differential; Female; He | 1993 |
Simultaneous steroids/interferon therapy in chronic hepatitis B.
Topics: Adult; Chronic Disease; Combined Modality Therapy; DNA, Viral; Female; Follow-Up Studies; Hepatitis | 1993 |
Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Contraindications; Cyclophosphamide; Cyta | 1996 |
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Churg-Strauss Syndrome; Clinical Protocols; Cyclo | 1996 |
Optimal immunosuppressive regimen for hepatitis B-positive kidney transplant recipients.
Topics: Actuarial Analysis; Adult; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Survival; H | 1996 |
Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carrier State; Chronic Disea | 1996 |
Acute hepatic injury after discontinuation of chemotherapy in a patient with non-Hodgkin's lymphoma and chronic hepatitis B virus infection.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cyclophosphamide; H | 1996 |
The effects of prednisolone and interferons on serum macrophage colony stimulating factor concentrations in chronic hepatitis B.
Topics: Adolescent; Adult; Alanine Transaminase; Child; Chronic Disease; Female; Hepatitis B; Humans; Interf | 1997 |
Acute exacerbation of hepatitis due to reactivation of hepatitis B virus with mutations in the core region after chemotherapy for malignant lymphoma.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; DNA | 1997 |
Severe hepatitis linked to B virus infection after withdrawal of low dose methotrexate therapy.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Fatal Outcome; Hepatitis B; Hepatitis B virus; Hu | 1998 |
[Exacerbation of hepatitis B and the expression of M proteinemia during the treatment of malignant lymphoma: a case study].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Doxorubicin; | 1999 |
[Fatal liver failure after corticosteroid therapy in hepatitis B carrier status].
Topics: Aged; Anti-Inflammatory Agents; Carrier State; Diagnosis, Differential; Fatal Outcome; Hemochromatos | 2000 |
[Current treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Anti-Inflammatory Agents; Antiviral Agents; DNA Replication; Famciclovir; Fo | 2001 |
Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B.
Topics: Acute Disease; Adult; Antiviral Agents; Combined Modality Therapy; Female; Glucocorticoids; Hepatiti | 2001 |
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cy | 2001 |
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxo | 2001 |
[Studies on juvenile chronic hepatitis].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Autoantibodies; Autoimmune Diseases; Azathioprine | 1975 |
[Can therapeutic measures cause a hepatitis virus infection to become chronic? (author's transl)].
Topics: Adolescent; Antineoplastic Agents; Chronic Disease; gamma-Globulins; Hepatitis A; Hepatitis B; Hepat | 1976 |
Behaviour of e antigen and antibody during chronic active liver disease. Relation to HB antigen-antibody system and prognosis.
Topics: Adolescent; Adult; Aged; Antibodies; Chronic Disease; Female; Hepatitis B; Hepatitis B Antibodies; H | 1976 |
Cell-mediated immunity and immunosuppressive therapy in HBsAg-positive chronic active hepatitis.
Topics: Azathioprine; Chronic Disease; Hepatitis B; Humans; In Vitro Techniques; Mitogens; Prednisone; Stimu | 1979 |
Jaundice after renal allotransplantation.
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Blood Transfusion | 1978 |
[ACTH in persistent chronic hepatitis in children].
Topics: Adrenocorticotropic Hormone; Bilirubin; Child; Child, Preschool; Hepatitis; Hepatitis B; Hepatitis B | 1979 |
[What can be said about the management of MBsAg-positive chronic hepatitis using steroids or immunosuppressive agents?].
Topics: Chronic Disease; Hepatitis B; Hepatitis B Antigens; Humans; Immunosuppressive Agents; Prednisone; Pr | 1979 |
[What can be said against the management of HBsAg-positive chronic hepatitis using steroids or immunosuppressive agents?].
Topics: Azathioprine; Chronic Disease; Hepatitis B; Hepatitis B Antigens; Humans; Immunosuppressive Agents; | 1979 |
[Hodgkin's disease developing in the course of a chronic liver disease with ulcerative colitis immunosuppressed with azathioprine].
Topics: Azathioprine; Colitis, Ulcerative; Hepatitis B; Hepatitis B Surface Antigens; Hodgkin Disease; Human | 1979 |
[Angio-immunoblastic lymphadenopathy and hepatitis B virus].
Topics: Aged; Hepatitis B; Humans; Immune System Diseases; Immunoglobulins; Lymphatic Diseases; Male; Predni | 1978 |
[Hemolytic anemia and viral hepatitis].
Topics: Adult; Anemia, Hemolytic; Female; Hepatitis B; Hepatitis B Antigens; Humans; Prednisone | 1978 |
Diagnosis and treatment of chronic active hepatitis.
Topics: Adolescent; Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Chronic Disease; Female; He | 1977 |
Hepatitis-associated lipid storage myopathy.
Topics: Adult; Biopsy; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lipid Metabolism, Inborn E | 1977 |
Cell-mediated immunity in acute and chronic hepatitis.
Topics: Acute Disease; Adult; Antibodies, Viral; Antigens, Viral; Bilirubin; Cell Line; Chromium Radioisotop | 1975 |
Letter: Treatment of cirrhosis with prednisone.
Topics: Alcoholism; Ascites; Female; Hepatitis; Hepatitis B; Humans; Liver Cirrhosis; Male; Prednisone; Sex | 1975 |
Thrombocytopenia complicating infectious hepatitis.
Topics: Blood Cell Count; Blood Platelets; Bone Marrow; Hepatitis B; Hepatitis B Antigens; Humans; Liver; Li | 1975 |
Studies on pure red cell aplasia. VII. Presence of proerythroblasts and response to splenectomy: a case report.
Topics: Adolescent; Anemia, Aplastic; Autoantibodies; Bone Marrow Cells; Bone Marrow Examination; Cells, Cul | 1975 |
Results of immunosuppressive treatment: Prognosis in chronic active hepatitis.
Topics: Chronic Disease; Drug Therapy, Combination; Follow-Up Studies; Hepatitis; Hepatitis B; Humans; Immun | 1975 |
Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Li | 1992 |
Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen.
Topics: Alanine Transaminase; Base Sequence; Blood; Chronic Disease; DNA, Viral; Follow-Up Studies; Hepatiti | 1992 |
[Polyarteritis nodosa and hepatitis B. A new therapeutic approach].
Topics: Child; Cyclophosphamide; Hepatitis B; Humans; Male; Polyarteritis Nodosa; Prednisone | 1991 |
Effects of alpha-interferon and prednisone on serum-soluble interleukin-2 receptor (sIL-2R) in chronic hepatitis B infection.
Topics: Adolescent; Adult; Alanine Transaminase; Chronic Disease; Female; Hepatitis B; Hepatitis B Antibodie | 1992 |
Alpha-interferon combined with immunomodulation in the treatment of chronic hepatitis B.
Topics: Adjuvants, Immunologic; Combined Modality Therapy; Hepatitis B; Hepatitis, Chronic; Humans; Interfer | 1991 |
[Antiviral therapy with recombinant alpha-interferon in chronic B virus hepatitis].
Topics: Chronic Disease; Hepatitis B; Hepatitis B Antigens; Humans; Interferon Type I; Male; Middle Aged; Pr | 1990 |
Normal growth of children with HBsAg positive chronic active hepatitis (CAH).
Topics: Age Determination by Skeleton; Child; Child, Preschool; Drug Administration Schedule; Female; Growth | 1991 |
Interferon-induced chronic active hepatitis?
Topics: Autoimmune Diseases; Hepatitis B; Hepatitis, Chronic; Humans; Interferon alpha-2; Interferon-alpha; | 1991 |
Monitoring hepatitis B virus replication.
Topics: DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Interferon Type I; Liver; Nucleic Acid Hybridiza | 1990 |
Exacerbation of chronic active hepatitis type B after short-term corticosteroid therapy resulting in fatal liver failure.
Topics: Adult; Contraindications; Hepatitis B; Hepatitis, Chronic; Humans; Male; Prednisone; Prognosis; Time | 1990 |
Short-term corticosteroid therapy for chronic active hepatitis B.
Topics: Adult; DNA-Directed DNA Polymerase; False Positive Reactions; Female; Hepatitis B; Hepatitis, Chroni | 1990 |
Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Female; Hepatitis B; Hepatit | 1990 |
Improvement of immune-complex nephritis associated with hepatitis B surface antigen excess.
Topics: Antigen-Antibody Complex; Female; Fluorescent Antibody Technique; Glomerulonephritis, Membranoprolif | 1989 |
Effect of prednisone on DR-positive T cells in children with chronic active hepatitis B.
Topics: Adolescent; Child; Hepatitis B; Hepatitis, Chronic; HLA-DR Antigens; Humans; Immunosuppression Thera | 1989 |
[Periarteritis nodosa related to hepatitis B virus. Determination of a new therapeutic strategy: 13 cases].
Topics: Combined Modality Therapy; Cyclophosphamide; Follow-Up Studies; Hepatitis B; Humans; Plasma Exchange | 1988 |
[Efficacy of glucocorticoid on the early stage of severe viral hepatitis].
Topics: Adult; Female; Hepatitis B; Hepatitis, Viral, Human; Humans; Male; Prednisone | 1988 |
Discontinuation of immunosuppressive therapy in hepatitis B surface antigen-positive chronic hepatitis: effect on viral replication and on liver cell damage.
Topics: Adult; Azathioprine; Chronic Disease; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surfa | 1987 |
[Failure to treat chronic asymptomatic hepatitis B virus carriers with short-term prednisone and adenine-arabinoside].
Topics: Adult; Carrier State; Drug Therapy, Combination; Hepatitis B; Humans; Male; Prednisone; Vidarabine | 1987 |
Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; DNA, Viral; Drug Therapy, Combination; Follow-Up Studi | 1987 |
Effect of thymosin immunostimulation with and without corticosteroid immunosuppression on chimpanzee hepatitis B carriers.
Topics: Animals; Azathioprine; Biopsy; Carrier State; Dexamethasone; Drug Therapy, Combination; Female; Hepa | 1987 |
Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Follow-Up Studies; Hepatitis B; Hepatitis B Core | 1985 |
[Therapy of liver diseases, possibilities and problems].
Topics: Anabolic Agents; Child; Cholestyramine Resin; Chronic Disease; Diet Therapy; Enzyme Induction; Femal | 1970 |
Lymphocyte transforming activity in the serum of patients with hepatic disease.
Topics: Autoradiography; Cholestasis; Culture Techniques; Cytidine; DNA Replication; Globulins; Hepatitis; H | 1971 |
Necrotizing angiitis in a methamphetamine user with hepatitis B--angiographic diagnosis, five-month follow-up results and localization of bleeding site.
Topics: Adult; Aneurysm; Angiography; Aortography; Follow-Up Studies; Hemoperitoneum; Hepatitis B; Heroin De | 1973 |
Pseudo-Chediak-Higashi anomaly in acute leukemia. A significant morphologic corollary?
Topics: Adult; Aged; Blood Transfusion; Carbenicillin; Cephalothin; Chediak-Higashi Syndrome; Cyclophosphami | 1974 |
Intravascular coagulation in systemic amyloidosis.
Topics: Acute Kidney Injury; Adrenal Glands; Aged; Amyloidosis; Anemia, Hemolytic; Anti-Bacterial Agents; Au | 1969 |
Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis).
Topics: Acute Disease; Adult; Biopsy; Female; Follow-Up Studies; Hepatitis; Hepatitis A; Hepatitis B; Hepati | 1970 |
Steroid therapy in massive hepatic necrosis due to viral hepatitis.
Topics: Adult; Female; Hepatic Encephalopathy; Hepatitis A; Hepatitis B; Hepatovirus; Humans; Male; Middle A | 1970 |
Over one and half years unmaintained remission in acute leukaemia.
Topics: Child; Common Cold; Hepatitis B; Humans; Influenza, Human; Leukemia, Lymphoid; Male; Mercaptopurine; | 1974 |
Serum complement after orthotopic transplantation of the human liver.
Topics: Adolescent; Adult; Azathioprine; Cholestasis; Chronic Disease; Complement System Proteins; Graft Rej | 1972 |
Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen.
Topics: Adult; Antibodies, Anti-Idiotypic; Aspartate Aminotransferases; Azathioprine; Bilirubin; Blood Prote | 1971 |
Infectious and serum viral hepatitis: differentiation with serum IgM and thymol turbidity as criteria.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Proteins; Diagnosis, Differential; Female; Hepatitis A | 1972 |
[Treatment of hepatitis].
Topics: Acute Disease; Chronic Disease; Hepatitis A; Hepatitis B; Humans; Prednisone | 1969 |
[A case of insulin-resistant diabetes mellitus].
Topics: Diabetes Mellitus; Drug Tolerance; Hepatitis B; Humans; Insulin; Insulin Resistance; Middle Aged; Pr | 1965 |